A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL
Condition:   Follicular Lymphoma Interventions:   Drug: Obinutuzumab;   Drug: Lenalidomide;   Drug: Bendamustine;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone Sponsor:   Ruijin Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2023 Category: Research Source Type: clinical trials